Expression of cytokines in mouse hepatitis B virus X gene-transfected model

Abstract

The expression profile in the mouse hepatitis B virus X (HBx)-transfected model was investigated in order to lay a foundation for further study on the implication of cytokines expression in hepatitis B virus (HBV) infection. Hydrodynamic injection method via the tail vein was used to establish the animal HBx-transfected model. By using microassay, the differential expression of gene in each group was analyzed, which was further confirmed by using real-time PCR and semi-quantitative PCR. Most of chemokine genes such as Ccl2, Ccl5, Ccl9, MIG and IP-10 were up-regulated in the HBx-transfected mouse model versus the control mice, which was coincided with the microarray results. Western blotting and immunohistochemistry were applied to detect the expression of MIG and IP-10 in the liver tissues. Simultaneously, ELISA was adopted to measure the content of IFN-γ in the liver tissues. DNA microassay revealed that the expression of 611 genes changed in HBx-transfected mice as compared with that in pCMV-tag2B-transfected mice, and most of the screened chemokines were up-regulated (including MIG and IP-10). Additionally, IFN-γ protein levels were increased by 20.7% (P<0.05) in pCMV-tag2B-HBx-transfected mice as compared with the untreated mice. IFN-γ protein levels were reduced by 53.9% (P<0.05) in pCMV-tag2B-transfected mice as compared with the untreated mice, which was consistent with the up-regulation of MIG and IP-10. It was suggested HBx transfection could induce the expression of MIG and IP-10 in the liver tissues, which might play the roles in HBV-related liver immunity and cytokines-mediated antiviral effect.

Keywords

hepatitis B virus / hepatitis B virus X protein / microarray / chemokines

References

[1] GanemD, VarmusHE. The molecular biology of the hepatitis B viruses. Annu Rev Biochem, 1987, 56: 651-693

[2] YangPL, AlthageA, ChungJ, et al.. Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection. P Natl Acad Sci USA, 2002, 99(21): 13825-3830

[3] HuZY, ZhangZS, KimJW, et al.. Altered proteolysis and global gene expression in hepatitis B virus X transgenic mouse Liver. J Virol, 2006, 80(3): 1405-1413

[4] KuoCY, WangJC, WuCC, et al.. Effects of hepatitis B virus X protein (HBx) on cell-growth inhibition in a CCL13-HBx stable cell line. Intervirology, 2008, 51(1): 26-32

[5] FeitelsonMA, SunB, SatirogluTNL, et al.. Genetic mechanisms of hepatocarcinogenesis. Oncogene, 2002, 21(16): 2593-2604

[6] MurakamiS. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol, 2001, 36(10): 651-660

[7] MaJ, SunT, ParkS, et al.. The role of hepatitis B virus X protein is related to its differential intracellular localization. Acta Biochim Biophys Sin, 2011, 43(8): 583-588

[8] XiaLM, HuangWJ, WuJG, et al.. HBx protein induces expression of MIG and increases migration of leukocytes through activation of NF-kappa B. Virology, 2009, 385(2): 335-342

[9] ZhouY, WangS, MaJW, et al.. Hepatitis B virus protein X-induced expression of the CXC chemokine IP-10 is mediated through activation of NF-kappa B and increases migration of leukocytes. J Biol Chem, 2010, 285(16): 12 159-12 168

[10] PanX, CaoH, LuJ, et al.. Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-κB. Mol Immunol, 2011, 48(12–13): 1573-1577

[11] ZhangX, YouX, WangQ, et al.. Hepatitis B virus X protein drives multiple cross-talk cascade loops involving NF-κB, 5-LOX, OPN and Capn4 to promote cell migration. PLoS One, 2012, 7(2): 31 458

[12] XuQ, PanX, ShuX, et al.. Increased interleukin-32 expression in chronic hepatitis B virus-infected liver. J Infect, 2012, 65(4): 336-342

[13] KakimiK, LaneTE, WielandS, et al.. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocyte. J Exp Med, 2001, 194(12): 1755-1766

[14] BaroneM, SpanoD, D’ApolitoM, et al.. Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis. Mol Med, 2006, 12(4–6): 115-123

[15] MaguireHF, HoefflerJP, SiddiquiA. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science, 1991, 252(5007): 842-844

[16] LinY, NomuraT, CheongJH, et al.. Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. J Biol Chem, 1997, 272(11): 7132-7139

[17] ShamayM, BarakO, DoitshG, et al.. Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription. J Biol Chem, 2002, 277(12): 9982-9988

[18] XiaL, TianD, HuangW, et al.. Upregulation of IL-23 expression in patients with chronic hepatitis B is mediated by the HBx/ERK/NF-κB Pathway. J Immunol, 2012, 188(2): 753-764

[19] CharoIF, RansohoffRM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med, 2006, 354(6): 610-621

[20] MainiMK, BoniC, LeeCK, et al.. The role of virus-specific CD8 (+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med, 2000, 191(8): 1269-1280

[21] XiangX, GuiH, KingNJ, et al.. IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver. Immunol Cell Biol, 2012, 90(6): 611-619

[22] PanCJ, WuHL, KuoSF, et al.. Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B. Hepatol Int, 2012, 6(3): 591-597

[23] ClarkEA, GolubTR, LanderES, et al.. Genomic analysis of metastasis reveals an essential role for RhoC. Nature, 2000, 406(6795): 536-540

[24] NestlA, Von SteinOD, ZatloukalK, et al.. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res, 2001, 61(4): 1569-1577

[25] MacDonaldTJ, BrownKM, LaFleurB, et al.. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet, 2001, 29(2): 143-152

[26] KhannaC, KhanJ, NguyenP, et al.. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res, 2001, 61(9): 3750-3759

[27] MaJ, HuangC, YaoX, et al.. Inhibition of hepatitis B virus and induction of hepatoma cell apoptosis by ASGPR-directed delivery of shRNAs. PLoS ONE, 2012, 7(10): e46096